CONNAUGHTON BERNADETTE sold 3.6% of their position (1.63K shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $107.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/2/2026ACC: 0001159036-26-000072
Director
Since Sep 2018
-1.63K
Net shares
Net seller
$107.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.63K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.63K
Price / share
$66.21
Trade value
$107.59K
% of position
3.6%
6/1/2026
45.29K→43.67K
Total
Net shares
−1.63K
Net value
-$107.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | S · Sale | −1.63K | $66.21 | $107.59K | 3.6% | 45.29K | 43.67K |
| Total | −1.63K | -$107.59K | ||||||
Derivative Transactions0
No derivative transactions reported